1. Home
  2. APGE vs MC Comparison

APGE vs MC Comparison

Compare APGE & MC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Apogee Therapeutics Inc.

APGE

Apogee Therapeutics Inc.

HOLD

Current Price

$132.75

Market Cap

4.7B

Sector

Health Care

ML Signal

HOLD

Logo Moelis & Company

MC

Moelis & Company

HOLD

Current Price

$66.68

Market Cap

4.9B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
APGE
MC
Founded
2022
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
4.7B
4.9B
IPO Year
2023
2014

Fundamental Metrics

Financial Performance
Metric
APGE
MC
Price
$132.75
$66.68
Analyst Decision
Strong Buy
Buy
Analyst Count
13
8
Target Price
$109.67
$72.88
AVG Volume (30 Days)
4.9M
906.8K
Earning Date
05-12-2026
04-29-2026
Dividend Yield
N/A
3.88%
EPS Growth
N/A
N/A
EPS
N/A
0.75
Revenue
N/A
N/A
Revenue This Year
N/A
$18.28
Revenue Next Year
N/A
$17.22
P/E Ratio
N/A
$87.23
Revenue Growth
N/A
N/A
52 Week Low
$34.34
$51.06
52 Week High
$133.16
$78.22

Technical Indicators

Market Signals
Indicator
APGE
MC
Relative Strength Index (RSI) 81.33 50.90
Support Level $73.70 $61.62
Resistance Level $133.16 $72.00
Average True Range (ATR) 2.11 2.59
MACD 3.45 -0.38
Stochastic Oscillator 99.20 54.01

Price Performance

Historical Comparison
APGE
MC

About APGE Apogee Therapeutics Inc.

Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.

About MC Moelis & Company

Moelis & Co is an independent investment bank that provides strategic and financial advice to a diverse client base, including corporations, financial sponsors, governments, and sovereign wealth funds. The company assists its clients in achieving their strategic goals by offering comprehensive, globally integrated financial advisory services across all industry sectors. It also advises clients on their critical decisions, including mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, and other corporate finance matters. It generates revenue from advisory transactions. The firm derives a majority of its revenue from the United States, followed by Europe and the rest of the World.

Share on Social Networks: